Mark N Levine

Mark N Levine

UNVERIFIED PROFILE

Are you Mark N Levine?   Register this Author

Register author
Mark N Levine

Mark N Levine

Publications by authors named "Mark N Levine"

Are you Mark N Levine?   Register this Author

93Publications

2268Reads

22Profile Views

A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.

Eur J Surg Oncol 2019 Aug 21;45(8):1341-1348. Epub 2019 Mar 21.

Department of Surgery, McMaster University, Hamilton, ON, Canada; Ontario Clinical Oncology Group, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2019.03.025DOI Listing
August 2019

Learning Health System for Breast Cancer: Pilot Project Experience.

JCO Clin Cancer Inform 2019 08;3:1-11

McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.19.00032DOI Listing
August 2019

Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay.

J Clin Oncol 2018 01 1;36(3):238-243. Epub 2017 Dec 1.

Nicole Mittmann, Sunnybrook Research Institute, Cancer Care Ontario, and University of Toronto; Craig C. Earle, Ontario Institute for Cancer Research; Craig C. Earle, Stephanie Y. Cheng, and Farah Rahman, Institute for Clinical Evaluative Sciences; Soo Jin Seung, Health Outcomes and PharmacoEconomic (HOPE) Research Centre, Sunnybrook Research Institute, Toronto; and Jim A. Julian and Mark N. Levine, Juravinski Cancer Centre, McMaster University, and Ontario Clinical Oncology Group, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.2577DOI Listing
January 2018

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

J Clin Oncol 2017 Jun 15;35(17):1884-1890. Epub 2017 Mar 15.

Charles N. Catton, Peter W.M. Chung, Patrick Cheung, Padraig Warde, and Tim K. Craig, University of Toronto, Toronto; Himu Lukka, Chu-Shu Gu, Theodoros Tsakiridis, Tom B. Corbett, Ian S. Dayes, Jim A. Julian, and Mark N. Levine, McMaster University, Hamilton; Glenn S. Bauman, University of Western Ontario, London, Ontario; Jean-Paul Bahary, University of Montreal, Montreal, Quebec; Shahida Ahmed, University of Manitoba, Winnipeg, Manitoba; Jackson S. Wu, University of Calgary, Calgary; Matthew B. Parliament, University of Alberta, Edmonton, Alberta, Canada; Jarad M. Martin, University of Newcastle, Newcastle, New South Wales; Keen Hun Tai, University of Melbourne, Melbourne, Victoria; Colin Tang, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; and Stéphane Supiot, University of Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.7397DOI Listing
June 2017

A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.

Lung Cancer 2017 02 15;104:65-69. Epub 2016 Dec 15.

Ontario Clinical Oncology Group, McMaster University, 711 Concession St, Hamilton, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.12.004DOI Listing
February 2017

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.

J Clin Oncol 2016 Apr 23;34(10):1065-71. Epub 2015 Nov 23.

Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton; Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton; Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton; Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto; Phillipe L. Bedard, Princess Margaret Hospital, Toronto; Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre; Toronto; and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8503DOI Listing
April 2016

A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2016 Mar 9;17(2):142-9. Epub 2015 Oct 9.

Department of Oncology, McMaster University, Hamilton, Ontario, Canada; Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada; Ontario Clinical Oncology Group, Juravinski Hospital, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.09.008DOI Listing
March 2016

A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial.

J Cancer Surviv 2015 Dec 21;9(4):683-91. Epub 2015 Apr 21.

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-015-0443-1DOI Listing
December 2015

Regional Nodal Irradiation in Early-Stage Breast Cancer.

N Engl J Med 2015 11;373(19):1878-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1510505DOI Listing
November 2015

Regional Nodal Irradiation in Early-Stage Breast Cancer.

N Engl J Med 2015 Jul;373(4):307-16

From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1415340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556358PMC
July 2015

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study.

J Bone Oncol 2015 Jun 12;4(2):47-53. Epub 2015 Jun 12.

Program for Cancer Therapeutics, Ottawa Hospital Research Institute, Box 926, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6 ; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbo.2015.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620970PMC
June 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.

Int J Radiat Oncol Biol Phys 2015 Apr;91(5):968-76

Ontario Clinical Oncology Group, Juravinski Cancer Centre at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.12.040DOI Listing
April 2015

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab.

Nucl Med Biol 2015 Feb 14;42(2):78-84. Epub 2014 Oct 14.

Department of Pharmaceutical Sciences, University of Toronto, Ontario, Canada; Department of Medical Imaging, University of Toronto, Ontario, Canada; Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2014.09.011DOI Listing
February 2015

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

J Clin Oncol 2015 Feb 20;33(6):654-6. Epub 2015 Jan 20.

Gary H. Lyman, Fred Hutchinson Cancer Research Center; Gary H. Lyman and Nicole M. Kuderer, University of Washington, Seattle, WA; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Alok A. Khorana, Cleveland Clinic, Cleveland, OH; Agnes Y. Lee, University of British Columbia, Vancouver, British Columbia; Mark N. Levine, McMaster University, Hamilton, Ontario, Canada; Juan Ignacio Arcelus, Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain; Edward P. Balaban, Cancer Care Partnership, Mount Nittany Health and Penn State Hershey Cancer Institute, State College, PA; Jeffrey M. Clarke, Duke University Medical Center, Durham; Nigel S. Key, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Christopher R. Flowers, Emory University School of Medicine, Atlanta, GA; Charles W. Francis, James P. Wilmot Cancer Center and University of Rochester, Rochester, NY; Leigh E. Gates, Patient Representative, Denver, CO; Ajay K. Kakkar, Thrombosis Research Institute, London, United Kingdom; Howard A. Liebman, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles; Margaret A. Tempero, University of California San Francisco Pancreas Center, San Francisco, CA; Sandra L. Wong, University of Michigan, Ann Arbor, MI; and Anna Falanga, Hospital Papa Giovanni XXIII, Bergamo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.7351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881372PMC
February 2015

Kit for the preparation of In-labeled pertuzumab injection for imaging response of HER2-positive breast cancer to trastuzumab (Herceptin).

Appl Radiat Isot 2015 Jan 23;95:135-142. Epub 2014 Oct 23.

Department of Pharmaceutical Sciences, University of Toronto, Ontario, Canada M5S 2M2; Department of Medical Imaging, University of Toronto, Ontario, Canada M5T 1W7; Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.apradiso.2014.10.011DOI Listing
January 2015

How long to treat acute venous thrombosis in cancer: can treatment be personalized?

J Clin Oncol 2014 Nov 29;32(32):3586-7. Epub 2014 Sep 29.

McMaster University; Juravinski Cancer Centre; and Escarpment Cancer Research Institute; Hamilton, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.6977DOI Listing
November 2014

Treating clots in cancer: moving closer to an answer?

Lancet Haematol 2014 Oct 28;1(1):e6-7. Epub 2014 Sep 28.

Department of Oncology, McMaster University; Ontario Clinical Oncology Group; Escarpment Cancer Research Institute; Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(14)70020-1DOI Listing
October 2014

Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer.

BMJ Open 2014 Oct 24;4(10):e006531. Epub 2014 Oct 24.

Ontario Clinical Oncology Group, Department of Oncology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2014-006531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212183PMC
October 2014

PET screening for metastatic colorectal adenocarcinoma--reply.

JAMA 2014 Sep;312(12):1256-7

McMaster University, Hamilton Health Sciences, Hamilton, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.9853DOI Listing
September 2014

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

Breast Cancer Res Treat 2014 Jul 13;146(1):153-62. Epub 2014 Jun 13.

Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa Hospital Research Institute and University of Ottawa, Box 912, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3015-6DOI Listing
July 2014

Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times.

Springerplus 2014 26;3:323. Epub 2014 Jun 26.

Ontario Clinical Oncology Group, Department of Oncology, McMaster University, 711 Concession Street - G (60) Wing 1st Floor, Hamilton, ON L8V 1C3 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2193-1801-3-323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087327PMC
July 2014

Cost effectiveness of a survivorship care plan for breast cancer survivors.

J Oncol Pract 2014 Mar 10;10(2):e86-92. Epub 2013 Dec 10.

University of Ottawa; Ottawa Hospital Research Institute; Applied Health Economics Research Unit, Ottawa; Ontario Institute for Cancer Research; University of Toronto, Toronto; Ontario Clinical Oncology Group; McMaster University; and Juravinski Regional Cancer Centre, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2013.001142DOI Listing
March 2014

Uptake of an innovation in surgery: observations from the cluster-randomized Quality Initiative in Rectal Cancer trial.

Can J Surg 2013 Dec;56(6):415-21

The Department of Surgery, McMaster University, St. Joseph's Healthcare, Hamilton, Ont., the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Ont., and the Department of Oncology, Faculty of Health Sciences, Juravinski Cancer Centre, Hamilton, Ont.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859785PMC
http://dx.doi.org/10.1503/cjs.019112DOI Listing
December 2013

Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.

J Clin Oncol 2013 Nov 8;31(32):4038-45. Epub 2013 Jul 8.

Ivo A. Olivotto, Tanya Berrang, Pauline T. Truong, Alan Nichol, Melanie Reed, and Wayne Beckham, British Columbia Cancer Agency; Ivo A. Olivotto, Tanya Berrang, and Pauline T. Truong, University of British Columbia; Wayne Beckham, University of Victoria, Victoria; Alan Nichol, University of British Columbia, Vancouver; Melanie Reed, University of British Columbia, Kelowna, British Columbia; Timothy J. Whelan, Do-Hoon Kim, Iwa Kong, and Mark N. Levine, Juravinski Cancer Centre; Timothy J. Whelan, Sameer Parpia, Do-Hoon Kim, Iwa Kong, Brandy Cochrane, Mark N. Levine, and Jim A. Julian, McMaster University; Timothy J. Whelan, Sameer Parpia, Brandy Cochrane, Mark N. Levine, and Jim A. Julian, Ontario Clinical Oncology Group, Hamilton; Anthony Fyles, Princess Margaret Hospital, University of Toronto, Toronto; Francisco Perera, London Regional Cancer Centre, University of Western Ontario, London, Ontario; Isabelle Roy, Hôpital Notre-Dame, University of Montreal, Montreal; Isabelle Germain, Hôtel-Dieu de Quebec, Laval University, Quebec City, Quebec; Mohamed Akra, Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba; and Theresa Trotter, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.5511DOI Listing
November 2013

Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer.

J Clin Oncol 2013 Oct 16;31(30):3758-63. Epub 2013 Sep 16.

Ian S. Dayes, Tim J. Whelan, Jim A. Julian, Sameer Parpia, and Mark N. Levine, McMaster University; Tim J. Whelan, Jim A. Julian, Sameer Parpia, Kathleen I. Pritchard, and Mark N. Levine, Ontario Clinical Oncology Group; Ian S. Dayes, Tim J. Whelan, and Mark N. Levine, Juravinski Cancer Centre; Donna Reise, Talspar Nursing Services; Jennifer Wiernikowski, Hamilton Health Sciences, Hamilton; Kathleen I. Pritchard and Lee Manchul, University of Toronto; Kathleen I. Pritchard, Odette Sunnybrook Cancer Centre; Lee Manchul, University Health Network, Toronto; David Paul D'Souza and Lyn Kligman, London Regional Cancer Program, London; David Paul D'Souza, University of Western Ontario, London, Ontario; Linda LeBlanc, Dr Leon Richard Oncology Centre, Moncton, New Brunswick; Margaret L. McNeely, University of Alberta; and Margaret L. McNeely, Cross Cancer Institute, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.7192DOI Listing
October 2013

Selective application of a test based on risk: using limited resources wisely.

J Clin Oncol 2013 Aug 15;31(23):2847-8. Epub 2013 Jul 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.4399DOI Listing
August 2013

Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.

BMC Med Res Methodol 2013 Mar 21;13:44. Epub 2013 Mar 21.

Ontario Clinical Oncology Group, Department of Oncology, McMaster University, 711 Concession Street - G (60) Wing 1st Floor, Hamilton, ON L8V 1C3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2288-13-44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610213PMC
March 2013

Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.

Thromb Res 2012 Dec 7;130(6):894-900. Epub 2012 Oct 7.

Ontario Clinical Oncology Group (OCOG), McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2012.09.010DOI Listing
December 2012

Method to our madness or madness in our methods? Pitfalls in trial methodology.

J Clin Oncol 2012 Jun 30;30(17):2025-7. Epub 2012 Apr 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.4912DOI Listing
June 2012

Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial.

Breast Cancer Res Treat 2012 Jan 1;131(2):541-51. Epub 2011 Nov 1.

Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1840-4DOI Listing
January 2012

Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients.

Pathophysiol Haemost Thromb 2010 23;37(2-4):88-97. Epub 2011 Mar 23.

Department of Oncology, McMaster University, Hamilton, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000324166DOI Listing
October 2011

Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia : a randomized trial in Canada and Brazil.

Cancer 2011 Apr 8;117(7):1438-45. Epub 2010 Nov 8.

Ontario Clinical Oncology Group, Department of Oncology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25635DOI Listing
April 2011

Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces.

Ann Surg Oncol 2010 Oct 13;17(10):2537-44. Epub 2010 Jul 13.

Department of Surgery, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1114-0DOI Listing
October 2010

Conventional and complementary therapies: a tale of two research standards?

Authors:
Mark N Levine

J Clin Oncol 2010 Apr 22;28(12):1979-81. Epub 2010 Mar 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.5320DOI Listing
April 2010

Thromboprophylaxis during chemotherapy: NO.

Authors:
Mark N Levine

Thromb Res 2010 Apr;125 Suppl 2:S16

Ontario Clinical Oncology Group, Henderson Research Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0049-3848(10)70006-2DOI Listing
April 2010

New antithrombotic drugs: potential for use in oncology.

Authors:
Mark N Levine

J Clin Oncol 2009 Oct 8;27(29):4912-8. Epub 2009 Sep 8.

Department of Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.7346DOI Listing
October 2009

Prevention of thrombosis in ambulatory patients with cancer.

J Clin Oncol 2009 Oct 14;27(29):4885-8. Epub 2009 Sep 14.

Department of Oncology, McMaster University and Juravinski Cancer Centre, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.5481DOI Listing
October 2009

Positron emission tomography in staging early lung cancer: a randomized trial.

Ann Intern Med 2009 Aug 6;151(4):221-8, W-48. Epub 2009 Jul 6.

Ontario Clinical Oncology Group, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00132DOI Listing
August 2009

Registries that show efficacy: good, but not good enough.

J Clin Oncol 2008 Nov 14;26(33):5316-9. Epub 2008 Oct 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.3996DOI Listing
November 2008

Surgical outcomes in women with ovarian cancer.

Can J Surg 2008 Oct;51(5):346-54

Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ont.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556534PMC
October 2008

Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial.

Breast Cancer Res Treat 2008 Jul 13;110(2):337-42. Epub 2007 Sep 13.

Department of Oncology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9727-0DOI Listing
July 2008

The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery.

BMC Surg 2008 Feb 15;8. Epub 2008 Feb 15.

Department of Surgery, McMaster University, St, Joseph's Healthcare, G838-50 Charlton Ave, East, Hamilton, Ontario, L8N 4A6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2482-8-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262058PMC
February 2008

Adjuvant therapy and thrombosis: how to avoid the problem?

Authors:
Mark N Levine

Breast 2007 Dec 27;16 Suppl 2:S169-74. Epub 2007 Aug 27.

Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2007.07.012DOI Listing
December 2007

Adjuvant chemotherapy for breast cancer--30 years later.

N Engl J Med 2006 Nov;355(18):1920-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe068204DOI Listing
November 2006

HER2 and responsiveness of breast cancer to adjuvant chemotherapy.

N Engl J Med 2006 May;354(20):2103-11

Toronto Sunnybrook Regional Cancer Centre and the University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa054504DOI Listing
May 2006

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.

J Clin Oncol 2006 Mar;24(9):1404-8

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.5600DOI Listing
March 2006

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.

J Clin Oncol 2006 Feb 17;24(6):848-55. Epub 2006 Jan 17.

Cancer Outcomes Research Program, Cancer Care Nova Scotia and Dalhousie University, Halifax, Nova Scotia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.2235DOI Listing
February 2006

The importance of reporting patient recruitment details in phase III trials.

J Clin Oncol 2006 Feb;24(6):843-5

Juravinski Cancer Centre at Hamilton Health Sciences, and Department of Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.6005DOI Listing
February 2006

Trastuzumab cardiac side effects: only time will tell.

Authors:
Mark N Levine

J Clin Oncol 2005 Nov;23(31):7775-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.1558DOI Listing
November 2005

Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients.

Thromb Haemost 2005 Jun;93(6):1185-8

London Health Sciences Centre, 800 Commissioners Road East, London, Ontario, N6A 4G5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH05-01-0052DOI Listing
June 2005

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

J Clin Oncol 2005 Apr 7;23(10):2123-9. Epub 2005 Feb 7.

Hamilton Health Science, Henderson Hospital, Room 9, 90 Wing, 711 Concession St, Hamilton, ON L8V 1C3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.133DOI Listing
April 2005

Pilot study of the quality initiative in rectal cancer strategy.

Dis Colon Rectum 2004 Oct;47(10):1594-8

Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10350-004-0658-0DOI Listing
October 2004

Thrombotic disorders: diagnosis and treatment.

Hematology Am Soc Hematol Educ Program 2003 :520-39

University of Pennsylvania School of Medicine, Department of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://pivnikav.ru/works/gemostaz/gemostaz_056.pdf
Web Search
http://dx.doi.org/10.1182/asheducation-2003.1.520DOI Listing
September 2004

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Chest 2004 Sep;126(3 Suppl):287S-310S

Henderson Research Centre, 711 Concession St, Hamilton, Ontario L8V 1C3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.126.3_suppl.287SDOI Listing
September 2004

Risk assessment and primary VTE prevention in the cancer patient.

Pathophysiol Haemost Thromb 2003 ;33 Suppl 1:36-41

McMaster University, Faculty of Health Sciences, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000073288DOI Listing
May 2004

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

J Clin Oncol 2004 May;22(10):1944-8

Department of Surgical Oncology and Technology, and Cancer Research UK Laboratories, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.10.002DOI Listing
May 2004

Researching the cost of research.

J Clin Oncol 2003 Nov 14;21(22):4081-2. Epub 2003 Oct 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.08.972DOI Listing
November 2003

Venous thromboembolism and cancer: risks and outcomes.

Circulation 2003 Jun;107(23 Suppl 1):I17-21

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.CIR.0000078466.72504.ACDOI Listing
June 2003

Can we optimise treatment of thrombosis?

Authors:
Mark N Levine

Cancer Treat Rev 2003 Jun;29 Suppl 2:19-22

Department of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Room 9, 90 Wing, Main Level, Henderson Hospital, 711 Concession Street, L8V 1C3, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0305-7372(03)80005-1DOI Listing
June 2003

Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer.

Authors:
Mark N Levine

Cancer Treat Rev 2002 Jun;28(3):145-9

McMaster University, Hamilton, Ont, Canada L8V IC3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0305-7372(02)00042-7DOI Listing
June 2002